New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

But for a brief moment on a recent December morning, Wedam, 19, who has sickle cell disease ... the procedure was successful. But antibodies in Wedam’s bloodstream prevented the same cure ...

Blood transfusions are a common medical procedure used to treat various conditions, including sickle cell disease ... a patient's immune system develops antibodies against transfused red blood ...

Can we predict that natural selection will weed out genetic disease over time? Sickle-cell trait haplotype distribution shows the genetic advantages of this mutation. In the deoxygenated ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

Beam Therapeutics has announced significant progress in its clinical trials and portfolio regarding precision genetic medicines, particularly in the area of sickle cell disease (SCD). Over 40 ...